MindImmune Therapeutics, Inc.
Monoclonal antibody therapeutic targeting immune cell infiltration into the brain
- Sector
- Biotech
- Headquarters
- KINGSTON, RI
- Founded
- 2016
- Latest Form D
- $10.2M, Dec 2025
- Total capital
- $16.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $16.3M
- 3 Form D · last Dec 2025
- 11 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 5 pending · first 2016
- Rank in peer group#28 of 502
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$10.2M
- Private capital raisedForm D · SEC · 2nd filing$5.3M
- Private capital raisedForm D · SEC · 1st filing$750K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#28 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bradley MargusDirectorNamed in SEC Form D filings
- Christopher O'DonnellDirectorNamed in SEC Form D filings
- Diane GoodingExecutive OfficerNamed in SEC Form D filings
- Frank S. MennitiExecutive Officer, DirectorNamed in SEC Form D filings
- Isaac StonerExecutive Officer, DirectorNamed in SEC Form D filings
- Reetika BhardwajDirectorNamed in SEC Form D filings
Show all 10 people
- Richard G. HoranDirectorNamed in SEC Form D filings
- Robert B. NelsonExecutive OfficerNamed in SEC Form D filings
- Stevin ZornExecutive Officer, DirectorNamed in SEC Form D filings
- Tracy SaxtonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 8- PendingDendritic Cell Recruitment From Blood To Brain In Neurodegenerative DiseaseUSPTOApplication 16761350
- PendingBenzamides-containing Compounds And Their Use In The Treatment Of DepressionUSPTOApplication 16283929
- PendingCyclic AminesUSPTOApplication 16156648
Show all 8 patent records
- Dendritic Cell Recruitment From Blood To Brain In Neurodegenerative DiseaseJun 17, 2021 · Application 16761350Pending
- Benzamides-containing Compounds And Their Use In The Treatment Of DepressionFeb 20, 2020 · Application 16283929Pending
- Cyclic AminesOct 10, 2019 · Application 16156648Pending
- Benzamides-containing Compounds And Their Use In The Treatment Of EpilepsyMar 26, 2019 · US 10,238,654Granted
- Cyclic AminesMar 14, 2017 · US 9,593,105Granted
- Cyclic AminesAug 16, 2016 · US 9,415,055Granted
- Dendritic Cell Recruitment From Blood To Brain In Neurodegenerative DiseaseApplication 62583959Pending
- Dendritic Cell Recruitment From Blood To Brain In Neurodegenerative DiseaseApplication PCTUS2018059761Pending
Related companies, and why
- Holobiome, Inc.Similar federal contract value in Biotech · null in contracts
- KHLORIS BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- PSY THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Phenovista Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- ELEGEN CORP.Similar federal contract value in Biotech · null in contracts
- JANGOBIO, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .